Cargando…

Association Between SCN1A rs2298771, SCN1A rs10188577, SCN2A rs17183814, and SCN2A rs2304016 Polymorphisms and Responsiveness to Antiepileptic Drugs: A Meta-Analysis

Background: SCN1A and SCN2A genes have been reported to be associated with the efficacy of single and combined antiepileptic therapy, but the results remain contradictory. Previous meta-analyses on this topic mainly focused on the SCN1A rs3812718 polymorphism. However, meta-analyses focused on SCN1A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mengmeng, Zhong, Rui, Lu, Yingxue, Zhao, Qian, Li, Guangjian, Lin, Weihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840883/ https://www.ncbi.nlm.nih.gov/pubmed/33519675 http://dx.doi.org/10.3389/fneur.2020.591828

Ejemplares similares

SCN9A rs6746030 Polymorphism and Pain Perception in Combat Athletes and Non-Athletes
por: Leźnicka, Katarzyna, et al.
Publicado: (2023)

Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

Data on mutations and Clinical features in SCN1A or SCN2A gene
por: Kong, Yanting, et al.
Publicado: (2018)

Homozygosity for the SCN10A Polymorphism rs6795970 Is Associated With Hypoalgesic Inflammatory Bowel Disease Phenotype
por: Gonzalez-Lopez, Eugene, et al.
Publicado: (2018)

Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells
por: Zhao, Yuanyuan, et al.
Publicado: (2016)

Influence of common SCN1A promoter variants on the severity of SCN1A‐related phenotypes
por: de Lange, Iris M., et al.
Publicado: (2019)

Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy
por: Hill, Sophie F., et al.
Publicado: (2023)

The rs6771157 C/G polymorphism in SCN10A is associated with the risk of atrial fibrillation in a Chinese Han population
por: Fang, Zhen, et al.
Publicado: (2016)

De novo mutations of SCN1A are responsible for arthrogryposis broadening the SCN1A-related phenotypes
por: Jaber, Dana, et al.
Publicado: (2021)

Delayed maturation of GABAergic signaling in the Scn1a and Scn1b mouse models of Dravet Syndrome
por: Yuan, Yukun, et al.
Publicado: (2019)

Novel presentation of SCN5A nonsense mutation as SCN5A overlap syndrome
por: Ahn, Hyo-Jeong, et al.
Publicado: (2021)

SCN1B and SCN2B gene variants analysis in dravet syndrome patients: Analysis of 22 cases
por: Gong, Jiao-E., et al.
Publicado: (2019)

Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy
por: Lu, Yuan, et al.
Publicado: (2020)

Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels
por: Baker, Mark D., et al.
Publicado: (2020)

SCN1A polymorphisms influence the antiepileptic drugs responsiveness in Jordanian epileptic patients
por: Abduljabbar, Rami, et al.
Publicado: (2023)

Characterization of maturation of neuronal voltage-gated sodium channels SCN1A and SCN8A in rat myocardium
por: Krause, Ulrich, et al.
Publicado: (2015)

SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients
por: Ricci, Maria Teresa, et al.
Publicado: (2014)

Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case–control study and meta-analysis
por: Wang, Zhi Jian, et al.
Publicado: (2018)

Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
por: Lenk, Guy M., et al.
Publicado: (2020)

An enhancer cluster controls gene activity and topology of the SCN5A-SCN10A locus in vivo
por: Man, Joyce C. K., et al.
Publicado: (2019)

Pathogenic in-Frame Variants in SCN8A: Expanding the Genetic Landscape of SCN8A-Associated Disease
por: Wong, Jennifer C., et al.
Publicado: (2021)

The possible effect of SCN1A and SCN2A genetic variants on carbamazepine response among Khyber Pakhtunkhwa epileptic patients, Pakistan
por: Nazish, Haleema Rehana, et al.
Publicado: (2018)

Association of SCN1A gene polymorphism with antiepileptic drug responsiveness in the population of Thrace, Greece
por: Angelopoulou, Christina, et al.
Publicado: (2016)

Neuropeptide Signaling Differentially Affects Phase Maintenance and Rhythm Generation in SCN and Extra-SCN Circadian Oscillators
por: Hughes, Alun T. L., et al.
Publicado: (2011)

Analysis of Genetic Variants in SCN1A, SCN2A, KCNK18, TRPA1 and STX1A as a Possible Marker of Migraine
por: Kowalska, Marta, et al.
Publicado: (2020)

A Complex Genomic Rearrangement Resulting in Loss of Function of SCN1A and SCN2A in a Patient with Severe Developmental and Epileptic Encephalopathy
por: Orlando, Valeria, et al.
Publicado: (2022)

Identification of five novel SCN1A variants
por: Zeng, Baitao, et al.
Publicado: (2023)

Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review
por: Mangano, Giuseppe Donato, et al.
Publicado: (2022)

Spectrum of SCN8A-Related Epilepsy
por: Morgan, Lindsey A., et al.
Publicado: (2015)

Heterozygous deletion of SCN2A and SCN3A in a patient with autism spectrum disorder and Tourette syndrome: a case report
por: Nickel, Kathrin, et al.
Publicado: (2018)

Meta-Analysis of Risk Stratification of SCN5A With Brugada Syndrome: Is SCN5A Always a Marker of Low Risk?
por: Yang, Yihan, et al.
Publicado: (2019)

Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: a case series
por: Sahli, Maryem, et al.
Publicado: (2019)

Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children: A protocol for systematic review and meta-analysis
por: Wen, Zhuangfei, et al.
Publicado: (2021)

Bidirectional Regulation of AdpA(ch) in Controlling the Expression of scnRI and scnRII in the Natamycin Biosynthesis of Streptomyces chattanoogensis L10
por: Yu, Pin, et al.
Publicado: (2018)

SCN1A and SCN1B gene polymorphisms and their association with plasma concentrations of carbamazepine and carbamazepine 10, 11 epoxide in Iranian epileptic patients
por: Namazi, Soha, et al.
Publicado: (2015)

SCN5A Variants: Association With Cardiac Disorders
por: Li, Wenjia, et al.
Publicado: (2018)

Modifier genes in SCN1A‐related epilepsy syndromes
por: de Lange, Iris M., et al.
Publicado: (2020)

Gaining Awareness of Increasingly Persistent SCN1A Mutations
por: Wong, Jennifer C.
Publicado: (2023)

Na(+) current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression
por: Zhang, Quan, et al.
Publicado: (2014)

SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families
por: Wijeyeratne, Yanushi D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_955r6j89e3k7isop2g6fhejcc3